At the Hospital Gregorio Marañón in Madrid, a groundbreaking medical procedure has been completed with the successful implantation of the world’s first personalized bone prosthetic made from metamaterial. The patient, a Frenchman named Pierre Chazel, was diagnosed with a high-grade osteosarcoma affecting his tibia. After undergoing surgery to remove the tumor while preserving his leg and joint, doctors faced the challenge of reconstructing part of the bone to allow the limb to support his body weight again. A collaborative effort between the hospital and the Universidad Politécnica de Madrid led to the creation of this innovative prosthetic, marking a major advancement in orthopedic care. The case began several years ago when Pierre, a 38-year-old man, was diagnosed with cancer. Following a radiograph and biopsy, he was found to have a rapidly growing high-grade osteosarcoma in his tibia. Initially, the prognosis suggested amputation below the knee, which would have drastically altered his quality of life. However, after treatment at the Gregorio Marañón Hospital, a national reference center for soft tissue and bone sarcomas, the situation changed. Surgeons successfully removed the tumor while keeping the leg intact, but reconstruction was necessary to restore function. Reconstructive efforts were complicated by the patient's condition. His bone had developed severe osteoporosis following the tumor removal, making standard prosthetics unsuitable. To address this, a multidisciplinary team including surgeons, biomedical engineers, and researchers from the Universidad Politécnica de Madrid developed a customized prosthetic using advanced materials. This device, composed of a metamaterial engineered to mimic the mechanical properties of bone, was designed specifically for Pierre’s unique anatomical requirements. The prosthetic was created through a process inspired by aerospace engineering. Engineers used mathematical modeling to replicate the structure of healthy bone, ensuring the implant would integrate seamlessly with the patient’s own tissue. The material, titanium, was optimized using metamaterial techniques, resulting in a lightweight yet durable structure capable of supporting weight and movement. The result was a prosthetic weighing just 150 grams, significantly lighter than traditional models, while maintaining the strength and stiffness of natural bone. During the implantation, a team of oncologic orthopedic surgeons performed the procedure, guided by the collaborative expertise of the research group. Post-surgery, Pierre reported immediate improvements. He described being able to carry objects in his hand without discomfort and walking without the need for crutches. “I can walk normally,” he stated during a video presentation, highlighting the success of the intervention. Rubén Pérez, the subdirector of scientific investigation at the IISGM and one of the lead surgeons, emphasized the significance of the achievement. He noted that avoiding amputation and preserving the entire joint represented a major breakthrough. The project, he explained, was the product of a collective effort combining clinical experience with academic innovation. “This represents a milestone in both scientific and clinical terms,” Pérez remarked, underscoring the potential for future applications. The hospital plans to expand the use of such prosthetics beyond individual cases. With approximately 2,600 new sarcoma diagnoses annually in Spain, the demand for advanced reconstructive solutions is clear. The team aims to develop standardized protocols to treat more patients efficiently. They have already operated on two additional individuals using similar technology and hope to refine their approach further. The success of this case highlights the intersection of cutting-edge engineering and medical science, offering new possibilities for patients facing complex orthopedic challenges. As the field continues to evolve, the integration of aerospace-inspired technologies into clinical practice promises to redefine rehabilitation options for those affected by serious bone conditions.
★
Keep the news honest.
ObjectiveNews is reader-funded and ad-free — we show you the bias instead of hiding it. Support independent journalism for €4/month.
Become a Supporter